Intrinsic Value of S&P & Nasdaq Contact Us

Processa Pharmaceuticals, Inc. PCSA NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
67/100
4/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$9.00
+213.6%

Processa Pharmaceuticals, Inc. (PCSA) has 17 known insider and institutional holders on record. The largest holder is BESSER JAMES E with 1,120,000 shares. Other notable holders include THOMPSON VIRGIL and Yorke Justin W.

Over the last 12 months, insiders have made 43 transactions in PCSA stock — 32 buys (valued at $43K) and 0 sells (valued at RSU Award). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.

PCSA Insider Ownership

Top Holder
BESSER JAMES E
1,120,000 shares
Buys (12 mo)
32
$43K value
Sells (12 mo)
0
$0.00 value
12-Month Transaction Activity
Buy 74%
Sell 0%
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Besser James E 10 Percent Owner 1,120,000 2021-05-05
100%
2 Thompson Virgil Director 100,213 2023-01-04
9%
3 Yorke Justin W Director 100,000 2025-10-03
9%
4 Floyd Robert Michael Chief Operating Officer 82,267 2023-02-10
7%
5 Glenview Capital Management Llc 10 Percent Owner 43,600 2004-09-03
4%
6 Islam Khalid Director 18,208 2022-04-19
2%
7 Young David Pres. Research & Development 10,562 2026-04-01
1%
8 Stanker James H Chief Financial Officer 6,120 2024-08-02
1%
9 Bigora Sian Chief Development Officer 3,711 2026-04-01
0%
10 Ng George K Chief Executive Officer 3,649 2026-04-01
0%
11 Lin Patrick Chief Business - Strategy Off 3,356 2026-04-01
0%
12 Guy Wendy Chief Administrative Officer 3,110 2026-04-01
0%
13 Baluch Khoso Director 2,325 2026-04-01
0%
14 Skibsted Russell Chief Financial Officer 2,324 2026-04-01
0%
15 Pannu Geraldine Director 2,188 2026-04-01
0%
16 Schoettler Gail Director 1,000 2004-04-12
0%
17 Neal James R Director 818 2026-04-02
0%
Recent Transactions (last 12 months)
Date Name Role Type Shares Price Value
2026-03-31 Neal James R Director Informative Buy 789 $2.54 $2K
2026-03-31 Pannu Geraldine Director Informative Buy 2,072 $2.54 $5.25K
2026-03-31 Bigora Sian Chief Development Officer Informative Buy 2,107 $2.54 $5.34K
2026-03-31 Lin Patrick Chief Business - Strategy Off Informative Buy 1,603 $2.54 $4.06K
2026-03-31 Guy Wendy Chief Administrative Officer Informative Buy 1,854 $2.54 $4.7K
2026-03-31 Baluch Khoso Director Informative Buy 2,269 $2.54 $5.75K
2026-03-31 Ng George K Chief Executive Officer Informative Buy 2,136 $2.54 $5.41K
2026-03-31 Young David Pres. Research & Development Informative Buy 1,810 $2.54 $4.59K
2026-03-31 Skibsted Russell Chief Financial Officer Informative Buy 2,324 $2.54 $5.89K
2026-01-01 Bigora Sian Chief Development Officer Option Exercise (Sell) 249 - -
2026-01-01 Lin Patrick Chief Business - Strategy Off Option Exercise (Sell) 193 - -
2026-01-01 Guy Wendy Chief Administrative Officer Option Exercise (Sell) 193 - -
2026-01-01 Young David Pres. Research & Development Option Exercise (Sell) 49 - -
2025-10-01 Pannu Geraldine Director RSU Award 100,000 - -
2025-10-01 Bigora Sian Chief Development Officer RSU Award 96,000 - -
2025-10-01 Lin Patrick Chief Business - Strategy Off RSU Award 68,000 - -
2025-10-01 Guy Wendy Chief Administrative Officer RSU Award 50,000 - -
2025-10-01 Baluch Khoso Director RSU Award 100,000 - -
2025-10-01 Ng George K Chief Executive Officer RSU Award 256,000 - -
2025-10-01 Neal James R Director RSU Award 100,000 - -
2025-10-01 Young David Pres. Research & Development RSU Award 111,000 - -
2025-10-01 Yorke Justin W Director RSU Award 100,000 - -
2025-10-01 Skibsted Russell Chief Financial Officer RSU Award 108,000 - -
2024-09-03 Pannu Geraldine Director RSU Award 31,206 - -
2025-07-24 Bigora Sian Officer Unknown - - -
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message